PBDEs and PBBs in human serum and breast milk from cohabiting UK couples  by Bramwell, Lindsay et al.
Chemosphere 116 (2014) 67–74Contents lists available at ScienceDirect
Chemosphere
journal homepage: www.elsevier .com/locate /chemospherePBDEs and PBBs in human serum and breast milk from cohabiting UK
coupleshttp://dx.doi.org/10.1016/j.chemosphere.2014.03.060
0045-6535/ 2014 The Authors. Published by Elsevier Ltd.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
⇑ Corresponding author. Tel.: +44 191 208 5673.
E-mail address: lindsay.bramwell@ncl.ac.uk (L. Bramwell).Lindsay Bramwell a,⇑, Alwyn Fernandes b, Martin Rose b, Stuart Harrad c, Tanja Pless-Mulloli a
a Institute of Health and Society, Medical Faculty, Newcastle University, Newcastle upon Tyne NE2 4AX, UK
b Food and Environment Research Agency, Sand Hutton, York YO41 1LZ, UK
cBirmingham University, School of Geography, Earth & Environmental Sciences, Birmingham B15 2TT, UK
h i g h l i g h t s
 UK body burdens of tri to deca PBDE and PBB are reported.
 Paired male and female serum, and female serum and breast milk were measured.
 These are the ﬁrst UK serum data since EU restrictions on PBDEs.
 A small reduction in median PPBDE3-7 UK serum levels are indicated.
 Estimated infant intakes are amongst the highest in the EU for BDEs-47 and -99.a r t i c l e i n f o
Article history:
Received 14 November 2013
Received in revised form 10 March 2014
Accepted 12 March 2014
Available online 16 April 2014
Handling Editor: H. Fiedler
Keywords:
PBDE
PBB
Human
Serum
Milk
UKa b s t r a c t
Concentrations of PBDEs and PBBs were measured in matched blood and breast milk samples from 10 UK
couples collected in 2011–12. These data are the ﬁrst measurements in human serum from the UK since
the 2004 EU ban on all uses of the penta-and octa-BDE formulations and the 2008 ban on the use of the
deca-BDE formulation in some applications. Serum
P
PBDE tri-hepta concentrations ranging from 1.0 to
16 ng g1 lipid weight, with median 4.0 ng g1 lw were measured. Breast milk
P
PBDE tri-hepta concen-
trations ranged from 1.3 to 21 ng g1 lw, with median 5.7 ng g1 lw. Couples had similar serum congener
concentrations unless one of them frequently stayed away from home for work (different diet and dust
exposures) or one had occupational exposure to foams and furnishings or electronics. BB-153 were mea-
sured above LOD in 40% of sera and 100% of breast milks samples, with median concentrations of 0.04 and
0.06, and maximums of 0.91 and 0.79 ng g1 lw respectively. Concentrations in this study indicated a
modest decrease from pre-ban levels reported for the UK. BDE-209 was detected above the limit of detec-
tion (LOD) in 15% of sera and 83% of breast milks, with ranges <1.2–20 and <0.2–1.0 ng g1 lw respec-
tively. Average daily infant intakes were estimated at 17, 5, 5 and 3 ng kg1 bw for BDE-47,-99,-153
and -209 respectively, all well below relevant US-EPA threshold reference dose values (RfDs).
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Polybrominated diphenyl ethers (PBDEs) and polybrominated
biphenyls (PBBs) are classes of ﬂame retardant that have been used
to meet ﬁre safety regulations for fabrics, furnishings, electronics
and vehicles since the 1970s. PBDEs are additive ﬂame retardants
that are mixed into plastics or foam, or sprayed onto fabrics, with-
out forming chemical bonds with the material. During the use and
lifetime of the product, PBDEs may migrate from the material
(Sjödin et al., 2003). PBDEs are now ubiquitous in indoor air anddusts (Harrad et al., 2010) and transfer into the wider environment
and food chains (Harrad and Diamond, 2006).
PBBs are another group of brominated ﬂame retardants similar
in structure, use, manufacture, contamination pathways and toxi-
cological impact to PCBs. Production in the USA ceased following
the Michigan Firemaster incident of 1973 where PBB was acciden-
tally introduced into animal feed. Their use as ﬂame retardants in
textiles was banned in the EU where they have not been used or
manufactured since 1996.
In 1999, Merionyté et al. noted a marked increase in concentra-
tions of PBDEs in the breast milk of Swedish women with
levels doubling approximately every four years (Meironyte et al.,
1999).This triggered a global interest in human body burden and
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mans and the environment. Inhalation and ingestion of indoor dust
and food are potential pathways of exposure to PBDEs. Mother to
child transfer of PBDEs occurs during breast feeding (Guvenius
et al., 2003; Carrizo et al., 2007). Potential adverse human health ef-
fects of PBDE exposure and body burden are reproductive toxicity,
neurotoxicity and immune effects (Darnerud et al., 2001; Meeker
et al., 2009; Gascon et al., 2012; Eskenazi et al., 2013). Evidence of
PBDE concentrations in indoor dusts and air in the UK has grown
in recent years (Santillo et al., 2003; Harrad et al., 2004, 2006,
2008a,b,c; Harrad and Hunter, 2006; Sjödin et al., 2008a; Harrad
and Abdallah, 2011) but few data are available regarding resultant
UK human body burdens. It is widely accepted that PBDEs have long
half-lives in humans but, even for the same congener, estimates of
these values vary widely. There is a general trend of shorter half-
lives for the more brominated compounds. Penta- and octa-BDE
were banned from use in the EU in 2004 (EU, 2004) with use of
deca-BDE in electronics and electrical goods also banned in 2008
(EU, 2008).
1.1. Aim
The aims of this study were to investigate (a) levels of PBDE and
PBBs in the sera of co-habiting UK couples, and (b) paired sera and
breast milk samples for nursing female partners. Measurements
were compared with previous UK data collected prior to the
implementation of EU restrictions on the manufacture and use
of PBDEs (EU, 2004, 2008). Concentrations of PBDEs in human
milk were used to derive estimated infant intakes of tri- to deca-
PBDEs.2. Materials and methods
Paired serum and breast milk samples were obtained from vol-
unteer couples living in the north east of England as part of a wider
in-depth study into potential human exposure sources and uptake
of PBDE and emerging brominated contaminants. The wider study
matches indoor dust and 24 h duplicate diet samples with these
serum and breast milks as well as room surveys, diaries and expo-
sure questionnaires, the results of which will be reported later.
Sampling was undertaken between April 2011 and February
2012. Ten couples took part in the study and women from six of
the couples provided breast milk samples.
2.1. Volunteer recruitment
We aimed to recruit individuals with a range of occupations and
diets to reﬂect low, medium and high exposure to PBDEs, such as
workers in electronics, soft furnishings or transport and outdoor
workers, oily ﬁsh eaters and vegetarians. A short pre-screening
questionnaire identiﬁed volunteers that would provide the opti-
mum range of exposures. Recruitment was via local universities,
local authorities, hospitals, playgroups and breast feeding groups.
79 couples completed the pre-screening questionnaires in 2011.
10 couples were invited, and agreed, to participate in the full study
week. Of these 10 couples, two repeated the sampling week as a
validation of the method. Inclusion in the study required the par-
ticipants to be over 18 years of age and to have six months or more
of domestic and occupational stability. Volunteers gave written in-
formed consent prior to participation. Ethical approval for the
study was provided by the NHS National Research Ethics
Committee North East, Durham and Tees Valley, the Newcastle
upon Tyne Hospitals NHS Foundation Trust, Newcastle University’s
Research Ethics Committee and the Food and Environment
Research Agency’s Ethics Committee.2.2. Sample collection
Volunteers visited the Clinical Research Facility (CRF) at the
Royal Victoria Inﬁrmary at Newcastle to provide 60 mL fasted
blood, sampled in the morning of the 8th day of the wider study.
Physical measurements, such as body mass index (BMI), were also
recorded at the CRF. Where a breast milk sample was provided,
P50 mL milk was collected by the volunteer by either pump or
manual expression up to 12 h before and 24 h after provision of
the blood sample. Blood samples were collected in 6  10 mL red-
top vacutainers, allowed to coagulate for 20 min, then centrifuged
at 1000 rpm to separate the serum which was frozen to 18 C and
stored at the CRF laboratory until analysis. Breast milk samples
were collected in Nalgene bottles and stored at 18 C until trans-
port with the sera samples to the Food and Environment Research
Agency (Fera) Laboratories, York, UK for analysis. A set of unused
sampling equipment was collected as ﬁeld blanks in case sample
results indicated a potential contamination source, however this
was not required. Two couples repeated the sampling week, with
sampling points 6.5 and 7.5 months apart. This provided a longitu-
dinal element to the study.
2.3. Laboratory analyses
Details of the methods used for sample preparation, extraction,
clean up and analysis of PBDEs and PBBs by high resolution GC MS
are described elsewhere (Fernandes et al., 2004 and Fernandes
et al., 2008). The performance characteristics of the methodology,
including QA parameters such as limits of detection (LODs), preci-
sion, linear range of measurement, recoveries etc. have been re-
ported earlier (Fernandes et al., 2008). Further conﬁdence in the
data is provided by regular and successful participation in inter-
comparison schemes such as POPs in Food 2012 (Bruun Bremnes
et al., 2012). The following congeners were measured: BDEs-17,
-28, -47, -49, -66, -71, -77, -85, -99, -100, -119, -126, -138, -153,
-154, -183 and -209 and PBBs -49, -52, -80, -101, -153 and -209.
Lipid determination was carried out by West Yorkshire Analytical
Services, Leeds, using the ISO17025 accredited Werner-Schmidt
method; acid hydrolysis and solvent extraction.
2.4. Data analysis
Data were normalised to ng g1 lipid for serum and breast milk
to enable comparison between matrices and with previous studies.
Descriptive statistics were calculated for both lower bound (LB)
and upper bound (UB) data, where concentrations <LOD are treated
as 0 and the LOD respectively.
2.5. Statistical analysis
Due to the small sample size statistical analyses were mostly
descriptive. Statistical analyses were carried out using lower
bound data, in keeping with previous UK serum data (Thomas
et al., 2006). The analyses used IBM SPSS Statistics for Windows,
Version 21.0. Armonk, NY: IBM Corp. Spearman’s correlation coef-
ﬁcients were determined between individual and sum congeners
and age, BMI, waist-hip ratio, total months breast feeding and
parity. The MannWhitney U test was used to determine any serum
differences between males and females, urban and rural inhabit-
ants and different diets.
2.6. Infant intake estimations
Nursing infants’ intakes of PBDEs were estimated by multiply-
ing age-appropriate estimated mean daily lipid intakes per kg
bodyweight by the lipid weight concentrations of PBDE congeners
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used were for a three months old infant (body weight 6.1 kg) with
average intake of 800 mL and higher intake 1200 mL. Whole
weight PBDE and PBB concentrations were used for the
calculations.
2.7. Risk assessment
Estimated BDE-47, -99 and -153 exposures were compared with
the corresponding threshold reference dose (RfD) suggested by the
US-EPA to determine whether the PBDE infant intakes estimated
for this study might be associated with any toxicological end-
points. RfDs are an estimate of oral daily human exposure to a
chemical at no-observed-adverse, non-carcinogenic effects levels
(NOAEL). For these PBDEs the endpoints considered by the
US-EPA are neurodevelopmental toxicological effects. The daily
exposures considered were BDE-47 (100 ng kg1) (US-EPA,
2006b), BDE-99 (100 ng kg1) (US-EPA, 2006a) and BDE-153
(200 ng kg1) (US-EPA, 2006c).
3. Results
Serum
P
PBDE tri-hepta concentrations ranged from 1.0 to
16 ng g1 lipid weight (lw), with a median concentration of
4.0 ng g1 lw. BDE-209 was detected above the LOD in 15% of sam-
ples, with a maximum of 19.8 ng g1 lw. Breast milk
P
PBDE tri-
hepta concentrations ranged from 1.3 to 21 ng g1 lw, with a med-
ian concentration of 5.7 ng g1 lw. BDE-209 was detected in 83% of
breast milk samples with a maximum of 1.04 ng g1 lw. BDE-47
was usually the most abundant congener present in sera in this
study, making up 40% (median) of the
P
PBDE tri-hepta. This was
followed by BDE-99 (20%), BDE-153 (9%), BDE-66 (6.5%) then
BDE-100 (3.7%) and BDE-49 (2.9%). In samples where BDE-209
was measured above LOD (15% detection rate) this congener com-
prised 40% (median) of the
P
PBDE. Results for PBDE congener con-
centrations in individual serum samples from couples 1 to 10 are
presented in Fig. 1. Repeat samples for couples 1 and 2 are also de-
picted. A summary of the serum data (not including repeat samples
for couples 1 and 2) and breast milk data is presented in Table 1,
including sums of all BDEs measured (
P
PBDE), all BDEs measured
excluding BDE-209 (
P
PBDE tri-hepta), BDE-47, -99, -100, -153,
-154 and -183 (
P
PBDE(6)), BDEs-47, -99 and -153 (
P
PBDE(3)).
Individual concentrations are provided in supplementary data
(Tables S-1 and S-2). BB-153 was the only PBB detected above
the LOD in sera in this study (40% detection rate). BB-153 wasFig. 1. Individual UK serum PBDE concentrations (ng g1 lw) for congdetected in 100% of breast milk samples and BB-101 in one sample.
PBB measurements are included in Table 1 and both supplemen-
tary data Tables S1 and S2.
A signiﬁcant negative association was found between
P
PBDE in
serum and age (Spearman’s rho r = 0.55, p = 0.01), but the associ-
ation with breast milk and age was not signiﬁcant (r = 0.09,
p = 0.87). The associations between
P
PBDE in serum and BMI
(r = 0.03, p = 0.89) or body fat mass (r = 0.07, p = 0.78) were
not found to be signiﬁcant and neither were
P
PBDE in breast milk
and BMI (r = 0.09, p = 0.87). For both congeners BDE-49 and BDE-66
in breast milk, the same signiﬁcant positive association was noted
with BMI (r = 0.845, p = 0.03). Signiﬁcant negative associations
were found for individual congeners in serum with waist-hip ratio
(WHR); BDE-28 (r = 0.46, p = 0.04); BDE-153 (r = 0.47, p = 0.04).
Parity was found to have a signiﬁcant negative association with
P
PBDE in females’ serum (r = 0.67, p = 0.04) and serum BDE-
153 (r = 0.69, p = 0.03). Associations between PPBDE in breast
milk and parity (r = 0.29, p = 0.57) or total months breastfeeding
(r = 0.26, p = 0.62) were weaker. However, signiﬁcant negative
associations were found between total months breastfeeding and
serum BDE-49 (r = 0.67, p = 0.04). Lipid normalised PPBDE data
indicated that males had higher PBDE body burdens than their cor-
responding female partners (7/10 cases). The median concentra-
tion of
P
PBDE tri-hepta in males (4.6 ng g1 lipid) was higher
than that for females (3.5 ng g1 lipid). However, the difference
was only signiﬁcant for BDE-153 (p = 0.03), with a weaker associa-
tion with BDE-209 (p = 0.7). A weak association was found be-
tween sera
P
PBDE and having a home in an urban or rural
environment (p = 0.32). For the two couples who provided two ser-
um samples, differences between PBDE or PBB congener concen-
trations from the ﬁrst and second samples were not generally
signiﬁcant, except for increases in BDE-28 (p = 0.02) and BDE-47
(p = 0.04).4. Discussion
This 2011/12 study documents UK serum and breast milk data
for PBDEs and PBBs. A modest decrease in UK serum PBDE concen-
trations since the EU bans was found. Compared to earlier studies,
participants were recruited from as wide a pool of socio-economic
class, occupation, diet and location as possible, with great focus on
the detail of information collected for each individual. The small
number of participants and the focus on breastfeeding mothers
means, however, that results are not representative of all UK resi-
dents’ exposures.eners with detection rate P50%: BDE-47, -99, -100, -153, -183.
Table 1
Summary of selecteda PBDE and PBB body burden concentrations for all study participants (ng g1 lw).
Congener Serum (n = 20) Breast milk (n = 6)
Median Range % > LOD Median Range % > LOD
LBh UBi Min Max LBh UBi Min Max
BDE-28 0.04 0.12 <0.03 0.55 55 0.09. 0.091.92 0.02 0.31 100
BDE-47 0.63 1.582 <0.36 4.87 60 1.92 1.92 0.32 13.09 100
BDE-49 0.06 0.12 <0.03 0.65 60 0.03 0.03 <0.02 <0.11 67
BDE-66 0.05 0.26 <0.03 0.79 55 0.03 0.03 <0.03 0.13 67
BDE-85 0.02 0.05 <0.02 0.26 50 0.04 0.04 <0.01 0.35 83
BDE-99 0.79 0.79 <0.26 5.61 70 0.88 0.88 0.12 3.74 100
BDE-100 0.15 0.15 <0.03 0.57 80 0.64 0.64 0.07 2.19 100
BDE-153 0.37 0.37 0.12 4.05 100 1.01 1.01 0.70 1.68 100
BDE-138 <LOD 0.07 0.03 0.19 5 0.02 0.02 <0.01 0.04 67
BDE-154 <LOD 0.06 <0.02 0.38 35 0.07 0.07 0.01 0.18 100
BDE-183 0.05 0.07 <0.03 0.33 60 0.05 0.05 0.02 0.23 100
BDE-209 <LOD 3.27 <1.24 19.80 15 0.52 0.54 <0.20 1.04 83
BB-153 <LOD 0.04 <0.01 0.91 40 0.08 0.08 0.06 0.79 100
P
PBDEsb 2.41 8.32 2.25 35.41 5.59 5.67 1.28 22.02
P
PBDEtri-heptac 2.41 4.03 1.01 15.61 4.76 4.84 1.28 21.03P
PBDE(6)d 2.23 3.12 0.80 12.82 4.59 4.59 1.25 20.09P
PBDE(3)e 1.98 2.85 0.73 11.53 3.88 3.88 1.14 5.89P
PBBtri-heptaf <LOD 0.37 <0.04 1.60 0.08 0.17 0.06 0.81P
PBBg <LOD 0.74 <0.09 2.27 0.08 0.22 0.06 0.86
Sample fat % 0.43 0.43 0.25 0.93 2.61 2.61 0.97 4.56
a Where % > LOD is over 15% for either serum or breast milk (BDE-17, -71, -77, -119, -126, and PBB-15, -49, -52, -80, -101, 209 measured but not reported here).
b Sum of all PBDE congeners measured.
c Sum of all PBDE congeners measured except BDE-209.
d Sum of BDE-47, -99, -100, -153, -154 and -183.
e Sum of BDE-47, -99 and -153.
f Sum of all PBB congeners measured except BB-209.
g Sum of all PBB congeners measured.
h Lower bound data.
i Upper bound data.
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serum and age was in line with some previous studies with greater
age range of adult participants (Fromme et al., 2009; Garí and Gri-
malt, 2013; Shi et al., 2013). A non-signiﬁcant negative association
was found with PBDE in serum and BMI in keeping with Jain who
found PBDE-153 and PBB-153 to be negatively associated, (Jain,
2013) and in contrast to Fitzgerald et al. who found a signiﬁcant
positive association (Fitzgerald et al., 2010). The present ﬁnding
that serum BDE-153 was signiﬁcantly higher for males was in con-
trast to the two earlier studies of cohabiting couples where gender
differences were found not to be signiﬁcant (Gomara et al., 2007;
Fromme et al., 2009).
To the authors’ knowledge, the only previous published UK
PBDE study is provided by Thomas et al., from samples collected
in 2003. This study had 154 participants from thirteen locations
across the mainland, including some from the general area of this
study. Thomas et al. suggested that their 154 volunteers were not
representative of the general UK population as they had a higher
proportion of women (68%) and vegetarians (12%) and thatTable 2
Comparison of serum PBDE content between UK studies (ng g1 lw).
Thomas et al. (2006) 2003 data This stud
Median LB (ng g1 lw) Range (ng g1 lw) % Detects Median L
BDE 28 <0.14 <0.14–10 27 0.04
BDE 47 0.82 <0.30–180 68 0.63
BDE 99 0.76 <0.16–150 41 0.79
BDE 100 <0.16 <0.17–390 92 0.15
BDE 153 1.7 <0.26–87 99 0.37
BDE 154 0.6 <0.15–4.4 86 <LOD
BDE 183 0.3 <0.14–1.8 55 0.05
BDE 209 <15 <15–240 7 <LOD
P
PBDE 5.6 0.63–420 100 2.408
% Fat 0.426sampling on weekdays might select against people in work. They
noted that the majority of mothers in their cohort breastfed, which
was also found in this study. This study had only one vegetarian
(5%). The median age was 37 years (range 26–43), Thomas et al.’s
being 41 (range 22–80). The median BMI was 26 (range 22–33)
for this study, Thomas et al.’s being 23 (18–43). Technological ad-
vances have reduced the LOD for analyses since 2003, most signif-
icantly for BDE-209. By considering ratios of data provided by
Thomas et al. and the equivalents from this study, indicators of po-
tential changes in UK body burdens were gauged. The data and ra-
tios are presented in Table 2. All median congener concentrations
for this study were lower than those reported by Thomas et al. ex-
cept for BDE-99, where the measurements were very similar. It is
likely that signiﬁcant reductions would take time to manifest due
to the long life of PBDE-containing items such as household and of-
ﬁce soft furnishings and electronics. The maximum concentrations
for individual congeners in 2003 were considerably higher (50
times) than those in our study (2011/12). The absence of similar
high maximum values in this study may indicate a downward shifty, 2011 data Ratio medians 2003/2011
B (ng g1 lw) Range (ng g1 lw) % Detects
<0.03–0.55 55
<0.36–4.87 60 1.26
<0.26–5.61 70 0.96
<0.03–0.57 80
0.12–4.05 100 4.72
<0.12–0.38 35 5.45
<0.03–0.33 60 2.73
<1.24–19.8 15
2.25–35.41 100 3.13
0.25–0.93
Table 3
Median concentrations of BB-153 (ng g1 lw) in human serum samples from different
countries.
Location Year Number BB-153 Reference Note
UK 2011–
12
20 0.04
(<0.01–0.9)
This study (Range)
China 2009–
10
21 0.024 Yang et al.
(2013)
Geometric mean
(gm)
China* 2009–
10
35 0.52 Yang et al.
(2013)
e waste
dismantlers (gm)
Greenland 2002–
4
99 1.2 Lenters et al.
(2013)
gm
Poland and
Ukraine
2002–
4
200 <LOQ Lenters et al.
(2013)
Northwest
USA
2004 2062 3.3 (1.4–
5.5)
Sjödin et al.
(2008b)
NHANES
* Occupationally exposed cohort.
Table 4
Comparison of median (range) PBDE measurements in UK breast milks (ng g1 lw).
Study Number Year Sum PBDE
tri-hepta
BDE-209
This study 6 2011–12 5.7 (1.3–21.0) 0.5 (0.2–1.0)
Abdallah and
Harrad
(2014)
28 2009 5.0 (0.2–26.1)a 0.3 (0.1–0.9)
D’Silva (2005) 10 Pooled
groups
2000–2 6.4 (0.7–19.3)
Kalantzi et al.
(2004)
54 2001–3 6.6 (0.3–69.0)
a tri-hexa
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more representative study is needed to fully evaluate this
hypothesis.
Medians and ranges for BDE-47, -99, -100 and -153 in sera for
this study are presented alongside examples from Europe, Asia
and North America in Fig. 2. These examples are for studies that in-
clude data for men and women together, and where occupational
exposure was not targeted. Human body burdens in North America
are approximately one to two orders of magnitude higher than
those found elsewhere in the developed world. This may be
explained by the history of ﬂame retardant regulations in the
USA and California in particular (Shaw et al., 2010). The UK has
more stringent ﬂame retardant furnishings regulations than main-
land Europe (EFRA, 2011) and the highest reported indoor dust
BDE-209 concentrations in Europe (Harrad et al., 2008a). However,
there is currently no evidence to suggest that penta- BDE use has
been any higher in the UK than in mainland Europe. Median results
for this study and previous UK ﬁgures indicate that BDE-209 and
P
BDEtri to hepta levels sit at the mid to lower end of European
data (Thomas et al., 2006; Gomara et al., 2007; Antignac et al.,
2009; Frederiksen et al., 2009; Fromme et al., 2009; Roosens
et al., 2009). Maximum UK values reported by Thomas et al. are
similar to those from the USA, indicating that some UK individuals
have had higher PBDE exposure.
To the authors’ knowledge, data presented here are the ﬁrst UK
PBB data for both human sera and breast milk. Previous studies
with such PBB measurements have often been focused around
the Michigan incident and its legacy. General population exposures
were sought for comparison with the present results and are
shown in Table 3. The median serum BB-153 concentration of
0.04 ng g1 lw (range < 0.01–0.9) for this study, is almost twoFig. 2. Median levels and ranges (minimum–maximum) of major PBDE congener concentrations in serum for this and some previous studies of general populations. bKalantzi
et al. (2011), cFromme et al. (2009), dZhu et al. (2009), eButtke et al. (2013), fSjödin et al. (2008b).
Table 5
Comparison of mean daily infant intake estimations (ng kg1 bw).
Average daily consumption scenario 800 mL High daily consumption scenario 1200 mL
BDE 47 BDE 99 BDE153 BDE 209 BDE 47 BDE 99 BDE153 BDE209
UK, This study (n = 6) 2012a 17 5 5 3 26 8 8 4
EU, EFSA (24 EU studies)b 0.6–14 <0.1–5 0.5–11 1.0–13 1.0–21 <0.1–8 0.7–17 1.0–20
China, Shi et al. (n = 103) 2013c 64 41 6 13 1109
NZ, Coakley et al. (n = 33) 2013d 11 3 3
UK, Abdallah and Harrad (n = 28) 2009e 19.3 4.2 6.5 1.8
UK, Kalantzi et al. (n = 54) 2003b 14 4 6
a Intakes are calculated for the scenario of a three month old infant weighing 6.1 kg using whole weight breast milk data.
b EFSA (2011) Intakes are calculated for the scenario of a three month old infant weighing 6.1 kg and assuming breast milk to contain 3.5% lipid.
c Shi et al. (2013) estimated daily maximums and a mean of 64 for BDE-209.
d Coakley et al. (2013) estimated daily median exposures.
e Abdallah and Harrad (2014) estimated the mean exposure for a 1 month old infant weighing 4.14 kg and consuming 24.4 g lipid day1.
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Inuit studies.
PBDE concentrations in breast milk samples for this study were
very similar to the two previous UK studies and current Birming-
ham UK study (Abdallah and Harrad, 2014). Data for comparison
are presented in Table 4. A slight reduction in the median
P
PBDE3-7 may be indicated by the two most recent studies.
BDE-209 was measured in 28 breast milk samples collected from
women in Birmingham, UK in 2009 with a median concentration
of 0.25 and a range <0.06–0.92 ng g1 lw (71% > LOQ) (Abdallah
and Harrad, 2014). These are broadly consistent with those re-
ported in this study, where the median concentration of BDE-209
was 0.54 ng g1 lw (range < 0.20–1.04 ng g1 lw).
Although a signiﬁcant negative association was found with
P
PBDE in females’ serum and parity, the association with breast
milk was negative but not signiﬁcant. Of the six women who pro-
vided breast milk samples for this study, three were primiparus
and three were feeding their second child. Parity has been reported
to have a decreasing association with
P
PBDE levels in breast milk
(Kang et al., 2010). For all women in the study, total breastfeeding
time prior to blood and breast milk sampling for this study ranged
from 0 to 60 months, with a median of 10 months. Although a sig-
niﬁcant negative association was found between total months
breastfeeding and BDEs-49 and -153 in females’ serum, the nega-
tive associations between PBDEs or PBBs in breast milk and breast
feeding were not found to be signiﬁcant. Signiﬁcant associations
were found between BDE-49 and BDE-66 in breast milk and BMI
in contrast with earlier studies that found no signiﬁcant associa-
tion between BMI and
P
PBDE in breast milk (Chao et al., 2010;
Thomsen et al., 2010). The positive association found between
age and BDE-153 in breast milk was not signiﬁcant, although ear-
lier studies have reported that the association is signiﬁcant (Koh
et al., 2010; Lignell et al., 2011) and increased PBDE levels in breast
milk with age has been reported (Chao et al., 2010). The breast
feeding mothers’ median age in this study (35 years, range 27–
39) was older than earlier studies by Koh et al. (30.5 years), Lignell
et al. (mean 28.7, range 19–41), Chao et al. (30.1, range 22–42), and
Kalantzi et al. (range 24–34). In a study of UK breast milk sampled
in 2003, the participants were from Lancaster (a small city in rural
north-west UK) and London (Kalantzi et al., 2004). Kalantzi et al.’s
London participants were found to have higher PBDE body burdens
suggesting higher concentrations in individuals residing in larger
cities. This study also noted a positive association between breast
milk
P
PBDE and urban living, although the difference was not
found to be signiﬁcant.
4.1. Infant intake via breast milk
The infant intake estimations in this study used the average
(800 mL) and high (1200 mL) daily consumption scenarios usedby the European Food Safety Authority (EFSA, 2011), and are pre-
sented in Table 5. Whole weight breast milk PBDE concentrations
were used for calculations. EFSA intakes are calculated for the sce-
nario of a three month old infant weighing 6.1 kg and assuming
breast milk to contain 3.5% lipid. Lipid content in breast milk sam-
ples for this study ranged from 0.97% to 4.56% (median 2.61%). Esti-
mated mean daily infant exposures of BDE-47,-99, -153 and -209
for earlier UK studies and some comparable data from the Europe,
China and New Zealand are also presented in Table 4. The esti-
mates in this study are very similar to the most recent UK esti-
mates (Abdallah and Harrad, 2014). BDE-47 and -99 estimates
are towards the top end of the EFSA EU data whilst BDE-153 and
-209 are more central. The infant intake estimations for BDE-47,
-99 and -153 in this study were compared with corresponding
US-EPA RfDs. Maximum values for high infant consumption for this
study were well within US-EPA guidelines. A NOAEL range of 18.8–
41.4 ng kg1 bw for BDE-99 has also been proposed (Bakker et al.,
2008). The maximum estimate of daily exposure to BDE-99
(20 ng kg1 bw) in this study is at the low end of this NOAEL. This
limited assessment indicates that BDE-47, -99 and -153 in UK
breast milk are unlikely to raise health concerns.
5. Conclusions
Evidence of current UK body burdens of PBDEs and PBBs is re-
ported. Although the study is limited in size, it was found that
the EU penta- and octa-BDE bans have yet to translate into sub-
stantial reductions in internal exposure of the UK population. Little
or no reduction in breast milk levels since 2003 has been found.
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